NDC 54868-3318 Glipizide

Product Information

Product Code54868-3318
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Glipizide
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Physicians Total Care, Inc.
Labeler Code54868
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
07-26-1994
Listing Expiration Date What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
12-31-2017
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
I
NDC Code Structure

Usage Information


Product Characteristics

Color(s)WHITE (C48325)
ShapeROUND (C48348)
Size(s)8 MM
Imprint(s)WATSON;460
Score2

Product Packages

NDC 54868-3318-1

Package Description: 30 TABLET in 1 BOTTLE, PLASTIC

NDC 54868-3318-2

Package Description: 100 TABLET in 1 BOTTLE, PLASTIC

NDC 54868-3318-3

Package Description: 60 TABLET in 1 BOTTLE, PLASTIC

NDC 54868-3318-5

Package Description: 90 TABLET in 1 BOTTLE, PLASTIC

NDC 54868-3318-6

Package Description: 360 TABLET in 1 BOTTLE, PLASTIC

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Product Details

Glipizide is product labeled by Physicians Total Care, Inc.. The product's dosage form is and is administered via form.


What are Glipizide Active Ingredients?

The following is the list of active ingredients in this product. An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

  • GLIPIZIDE (UNII: X7WDT95N5C)
  • GLIPIZIDE (UNII: X7WDT95N5C) (Active Moiety)


NDC to RxNorm Crosswalk

What is RxNorm? RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:


Inactive Ingredient(s)

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • COLLOIDAL SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
  • CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
  • ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
  • CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
  • STARCH, CORN (UNII: O8232NY3SJ)
  • STEARIC ACID (UNII: 4ELV7Z65AP)


* Please review the disclaimer below.

Patient Education

Glipizide

Glipizide is pronounced as (glip' i zide)

Why is glipizide medication prescribed?
Glipizide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally ...
[Read More]

* Please review the disclaimer below.

Glipizide Labeling and Warnings

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



* Please review the disclaimer below.